Cargando…

Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all‐cause mortality

PURPOSE: The generalisability of randomised controlled trials (RCTs) may be limited by restrictive entry criteria or by their experimental nature. Observational research can provide complementary findings but is prone to bias. Employing propensity score matching, to reduce such bias, we compared the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillespie, Iain A., Floege, Jürgen, Gioni, Ioanna, Drüeke, Tilman B., de Francisco, Angel L., Anker, Stefan D., Kubo, Yumi, Wheeler, David C., Froissart, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033013/ https://www.ncbi.nlm.nih.gov/pubmed/26011775 http://dx.doi.org/10.1002/pds.3789

Ejemplares similares

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
por: Wheeler, David C., et al.
Publicado: (2014)

Development and validation of a predictive mortality risk score from a European hemodialysis cohort
por: Floege, Jürgen, et al.
Publicado: (2015)

Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes
por: Louie, Karly S., et al.
Publicado: (2019)

High cardiovascular event rates occur within the first weeks of starting hemodialysis
por: Eckardt, Kai-Uwe, et al.
Publicado: (2015)

The effects of discontinuing cinacalcet at the time of kidney transplantation
por: Jadoul, Michel, et al.
Publicado: (2010)

Reducing Bias in Cancer Research: Application of Propensity Score Matching
por: Reeve, Bryce B., et al.
Publicado: (2008)

Cinacalcet: the chemical parathyroidectomy?
por: Bellasi, Antonio, et al.
Publicado: (2013)

Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy
por: Rivelli, Gabriel Giollo, et al.
Publicado: (2020)

Effects of cinacalcet treatment on QT interval in hemodialysis patients
por: Temiz, Gökhan, et al.
Publicado: (2016)

Double propensity-score adjustment: A solution to design bias or bias due to incomplete matching
por: Austin, Peter C
Publicado: (2016)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Cinacalcet in HIV haemodialysis patients
por: Belmouaz, Simohamed, et al.
Publicado: (2008)

Hypercalcemia of malignancy treated with cinacalcet
por: Asonitis, Nikolaos, et al.
Publicado: (2017)

Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends
por: Lafrance, Jean-Philippe, et al.
Publicado: (2013)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events Trial
Publicado: (2015)

Association Between Resistance to Cinacalcet and Parathyroid Gland Hyperplasia in Kidney Transplant Recipients with Persistent Hypercalcemia
por: Oruc, A., et al.
Publicado: (2020)

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
por: Floege, Jürgen, et al.
Publicado: (2011)

Hospitalization and mortality following non-attendance for hemodialysis according to dialysis day of the week: a European cohort study
por: Fotheringham, James, et al.
Publicado: (2020)

Survival on four compared with three times per week haemodialysis in high ultrafiltration patients: an observational study
por: Fotheringham, James, et al.
Publicado: (2020)

Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia
por: Sethi, Bipin Kumar, et al.
Publicado: (2017)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2016)

The Effect of the Frequently Used Cinacalcet for pHPT during the COVID-19 Pandemic on Perioperative Decrease in Parathyroid Hormone
por: Radulova-Mauersberger, Olga, et al.
Publicado: (2022)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
por: Moyes, V. J., et al.
Publicado: (2010)

A novel asymmetric synthesis of cinacalcet hydrochloride
por: Arava, Veera R, et al.
Publicado: (2012)

Understanding the effect of loneliness on unemployment: propensity score matching
por: Morrish, N, et al.
Publicado: (2022)

OR03-05 Cinacalcet Acts As A Spatially Biased Allosteric Modulator To Enhance CaSR Signaling From Endosomal Membranes
por: Wyatt, Rachael, et al.
Publicado: (2023)

Effective Learning During COVID-19: Multilevel Covariates Matching and Propensity Score Matching
por: Guo, Siying, et al.
Publicado: (2022)

The effect of dobutamine in sepsis: a propensity score matched analysis
por: Zhu, Youfeng, et al.
Publicado: (2021)

Comparison of AMG 416 and cinacalcet in rodent models of uremia
por: Walter, Sarah, et al.
Publicado: (2014)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
por: Jeong, Sohyun, et al.
Publicado: (2016)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018)

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
por: Ng, Cheng Han, et al.
Publicado: (2020)

Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism
por: Timmons, J. G., et al.
Publicado: (2021)

Successful Early Treatment of Severe Neonatal Hyperparathyroidism With Cinacalcet
por: Thakkar, Keya, et al.
Publicado: (2021)

Hypercalcemia of Malignancy Complicated by Osteonecrosis of the Jaw Treated With Cinacalcet
por: Vasquez, Libia, et al.
Publicado: (2023)

Potential utility of cinacalcet as a treatment for CDC73-related primary hyperparathyroidism: a case report
por: Sato, Takeshi, et al.
Publicado: (2016)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

Bone biopsy in chronic kidney disease: still an option?
por: Drueke, Tilman B.
Publicado: (2020)

Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
por: Nakayama, Kazunori, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_igk2gb22tfi60r4tgv49s0ga3q